Delivery Order SPE2DB20D3505-SPE2DB24FV1A2

Award Date 9/26/24
Potential Completion Date 9/27/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML. The $2,143.20 firm-fixed-price delivery order contract has a completion date of September 18, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for providing a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,015.21, is for the delivery of 4566736890 - SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of December 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $37,562.52, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of 4566188588 - SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. This contract award is...
This federal contract award, valued at $7,260.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566758386 SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a specialty medication likely used for the treatment of migraine headaches. The contract has an ultimate completion date of December 19, 2024 and is a firm fixed-price delivery order. This award is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,770.80 firm fixed-price delivery order is for the supply of 4566262359 - Sumatriptan 6 mg/0.5 ml auto-injector, 0.5 ml. The contract has an ultimate completion date of October 30, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
This federal contract award, valued at $5,473.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566529235 - SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a medication used to treat migraines. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical division....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,410.97 Firm Fixed Price Delivery Order is for the supply of SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a prescription medication. The contract has a completion date of December 13, 2024 and was awarded on December 12, 2024. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a $1,927.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Sumatriptan 6 mg/0.5 mL autoinjectors. The contract has an ultimate completion date of November 25, 2024 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,653.88 firm fixed-price delivery order is for the supply of 4,565,752,700 units of the drug Sumatriptan 6 mg/0.5 ml autoinjector. The award has an ultimate completion date of September 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $15,166.62, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of 4566491985 - SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 20, 2024 and a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB24FV1A2
    Delivery Order

This federal contract award, valued at $1,027.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4565951667 SUMATRIPTAN 6 MG/0.5ML AUTOINJ 0.5ML, with a completion date of September 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract is not designated as a set-aside requirement.

Generated 2/27/25, 12:32 PM